Breaking News

Senior Management Changes at Lilly

Longtime leaders to retire

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Effective January 1, Dave Ricks, president of Lilly USA, will succeed Bryce D. Carmine as senior vice president and president of Lilly Bio-Medicines. Mr. Ricks’ responsibilities will include the U.S., Japan, and Europe. Bio-Medicines encompasses the therapeutic areas of neuroscience, cardiovascular, autoimmunity, musculoskeletal, and urology. Maria Crowe, senior vice president for global drug product manufacturing, will succeed Frank Deane, Ph.D. as president of manufacturing operations, also e...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters